SBIR/STTR Research Award
A wearable device to detect opioid overdose and to prevent death
Award amount
$225,000Program and phase
SBIR · Phase IAward year
2018Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Bioresp Technologies, Inc.
- Proposal award date
- 2018-05-01
- Contract end date
- 2019-03-31
- UEI
- Not reported
- Solicitation number
- PA16-302
- Topic code
- NIDA
Research abstract
Bioresp TechnologiesIncproposes development of RespiLifea new wearable device to to track
physiologic data for early detection of opioid overdose and to relay data and the generated alerts
to relevant caregivers for further interventionThe goal is to reduce the number opioids related
deaths by early detection of overdoseOpioid epidemic death toll has quadrupled sinceAbout half of those deaths are due to prescription opioids and for the most part are unintentionalRespiLife tracks oxygen saturationrespiratory rateand pulse rate and based on a machine
learning algorithm will determine changes from the baseline and correlation of those changes with
changes in medicationsOur specific aims areProduction of five working prototypes with their
algorithm to use in our validation studyA validation study to compare our data with a
gold standard device and carry out statistical analysis for evaluation of agreement and accuracy Public health relevanceCurrently we in the midst of an opioid overdose epidemic that has resulted in a four fold
increase in death rate since
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)